• Mashup Score: 0

    Review Article from The New England Journal of Medicine — The Vaccine-Hesitant Moment

    Tweet Tweets with this article
    • .@NEJM: Chris Murray at @IHME_UW and colleagues address the dynamic nature of #vaccine hesitancy and call for open & ongoing dialogue to identify & address emerging concerns early. Map: Rates of vaccine #hesitancy by 🇺🇸 ZIP Codes, December 2021. https://t.co/j2kQ3CkSvv #NIHCEAL https://t.co/avnBBAvil0

  • Mashup Score: 0

    Despite an overwhelming majority of rheumatologists reporting comfort and familiarity with biosimilars, 65% said they are “unlikely” to switch their patients from reference products until there is greater payer adoption, according to data. In a new report on 2022 trends in biosimilar use released by multinational health care services company Cardinal Health, 98% of surveyed

    Tweet Tweets with this article
    • “Research from other areas like #oncology shows #hesitancy among providers is common when #biosimilars are initially introduced, but concerns tend to drop significantly once physicians gain firsthand experience,” Dr. Gordon Lam told @HealioRheum https://t.co/tI86W9A2Ln